Serogroup B Meningococcal (MenB) Information

On October 23, 2015 the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) issued a policy regarding the use of serogroup B meningococcal (MenB) vaccine.  It indicates that a MenB vaccine may be administered to adolescents aged 16-23 to provide short term protection against most strains of serogroup B meningococcal disease.  

The complete report can be found here:

Bishop Wellness Center carries and provides the quadrivalent meningococcal conjucate vaccine (MenACWY) to students who request it.  We do not carry the MenB vaccines (most commonly Bexsero or Trumenba). 

However, several pharmacies close to campus have it available, or can order it.  Importantly, these vaccines are billed as a prescription, and insurance coverage varies significantly by plan.  Please contact your insurance provider for more information regarding coverage.

Centers for Disease Control and Prevention Information on Meningitis

The most recent Meningitis Vaccine Information Statement from the CDC can be found here: